Fig. 3From: Bevacizumab for radiation necrosis following radiotherapy of brain metastatic disease: a systematic review & meta-analysisSensitivity analysis of studies that used comparatively similar methods for estimation of reduction rates. Results are shown as forest plot of meta-analysis of mean reduction rate on T1-contrast enhanced MRI (a) and T2W FLAIR MRI (b)Back to article page